🇺🇸 FDA
Pipeline program

BT1718

CRUKD/17/009

Phase 2 small_molecule completed

Quick answer

BT1718 for Advanced Solid Tumours is a Phase 2 program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).

Program details

Company
BICYCLE THERAPEUTICS
Indication
Advanced Solid Tumours
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials